Discovery - University of Dundee - Online Publications

Library & Learning Centre

Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells

Standard

Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells. / Turban, S.; Stretton, C.; Drouin, O.; Green, C.J.; Watson, M.L.; Gray, A.; Ross, F.; Lantier, L.; Viollet, B.; Hardie, D.G.; Hundal, H.S.; Marette, A.

In: Journal of Biological Chemistry, Vol. 287, No. 24, 08.06.2012, p. 20088-20099.

Research output: Contribution to journalArticle

Harvard

Turban, S, Stretton, C, Drouin, O, Green, CJ, Watson, ML, Gray, A, Ross, F, Lantier, L, Viollet, B, Hardie, DG, Hundal, HS & Marette, A 2012, 'Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells' Journal of Biological Chemistry, vol 287, no. 24, pp. 20088-20099.

APA

Turban, S., Stretton, C., Drouin, O., Green, C. J., Watson, M. L., Gray, A., Ross, F., Lantier, L., Viollet, B., Hardie, D. G., Hundal, H. S., & Marette, A. (2012). Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells. Journal of Biological Chemistry, 287(24), 20088-20099, doi: 10.1074/jbc.M111.330746

Vancouver

Turban S, Stretton C, Drouin O, Green CJ, Watson ML, Gray A et al. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells. Journal of Biological Chemistry. 2012 Jun 8;287(24):20088-20099.

Author

Turban, S.; Stretton, C.; Drouin, O.; Green, C.J.; Watson, M.L.; Gray, A.; Ross, F.; Lantier, L.; Viollet, B.; Hardie, D.G.; Hundal, H.S.; Marette, A. / Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.

In: Journal of Biological Chemistry, Vol. 287, No. 24, 08.06.2012, p. 20088-20099.

Research output: Contribution to journalArticle

Bibtex - Download

@article{f251022beed0430d92eed1d454125f6a,
title = "Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells",
author = "S. Turban and C. Stretton and O. Drouin and C.J. Green and M.L. Watson and A. Gray and F. Ross and L. Lantier and B. Viollet and D.G. Hardie and H.S. Hundal and A. Marette",
year = "2012",
volume = "287",
number = "24",
pages = "20088--20099",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells

A1 - Turban,S.

A1 - Stretton,C.

A1 - Drouin,O.

A1 - Green,C.J.

A1 - Watson,M.L.

A1 - Gray,A.

A1 - Ross,F.

A1 - Lantier,L.

A1 - Viollet,B.

A1 - Hardie,D.G.

A1 - Hundal,H.S.

A1 - Marette,A.

AU - Turban,S.

AU - Stretton,C.

AU - Drouin,O.

AU - Green,C.J.

AU - Watson,M.L.

AU - Gray,A.

AU - Ross,F.

AU - Lantier,L.

AU - Viollet,B.

AU - Hardie,D.G.

AU - Hundal,H.S.

AU - Marette,A.

PY - 2012/6/8

Y1 - 2012/6/8

N2 - The importance of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) as effectors of metformin (Met) action on glucose uptake (GU) in skeletal muscle cells was investigated. GUin L6 myotubes was stimulated 2-fold following 16 h of Met treatment and acutely enhanced by insulin in an additive fashion. Insulin-stimulatedGUwas sensitive to PI3K inhibition, whereas that induced by Met was not. Met and its related biguanide, phenformin, stimulated AMPK activation/phosphorylation to a level comparable with that induced by the AMPK activator, 5-amino-1-ß-D-ribofuranosyl-imidazole-4-carboxamide (AICAR). However, the increase in GU elicited by AICAR was significantly lower than that induced by either biguanide. Expression of a constitutively active AMPK mimicked the effects of AICAR on GU, whereas a dominant interferingAMPK or shRNA silencing of AMPK prevented AICAR-stimulated GU and Met-induced AMPK signaling but only repressed biguanide- stimulated GU by ~20%. Consistent with this, analysis of GU in muscle cells from a1 /a2 AMPK-deficient mice revealed a significant retention of Met-stimulated GU, being reduced by ~35% compared with that of wild type cells. Atypical PKCs (aPKCs) have been implicated in Met-stimulated GU, and in line with this, Met and phenformin induced activation/phosphorylation of aPKC in L6 myotubes. However, although cellular depletion of aPKC (>90%) led to loss in biguanide-induced aPKC phosphorylation, it had no effect on Met-stimulated GU, whereas inhibitors targeting novel/conventional PKCs caused a significant reduction in biguanide-induced GU. Our findings indicate that although Met activates AMPK, a significant component of Met-stimulated GU in muscle cells is mediated via an AMPK-independent mechanism that involves novel/conventional PKCs. © 2012 by The American Society for Biochemistry and Molecular Biology, Inc.

AB - The importance of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) as effectors of metformin (Met) action on glucose uptake (GU) in skeletal muscle cells was investigated. GUin L6 myotubes was stimulated 2-fold following 16 h of Met treatment and acutely enhanced by insulin in an additive fashion. Insulin-stimulatedGUwas sensitive to PI3K inhibition, whereas that induced by Met was not. Met and its related biguanide, phenformin, stimulated AMPK activation/phosphorylation to a level comparable with that induced by the AMPK activator, 5-amino-1-ß-D-ribofuranosyl-imidazole-4-carboxamide (AICAR). However, the increase in GU elicited by AICAR was significantly lower than that induced by either biguanide. Expression of a constitutively active AMPK mimicked the effects of AICAR on GU, whereas a dominant interferingAMPK or shRNA silencing of AMPK prevented AICAR-stimulated GU and Met-induced AMPK signaling but only repressed biguanide- stimulated GU by ~20%. Consistent with this, analysis of GU in muscle cells from a1 /a2 AMPK-deficient mice revealed a significant retention of Met-stimulated GU, being reduced by ~35% compared with that of wild type cells. Atypical PKCs (aPKCs) have been implicated in Met-stimulated GU, and in line with this, Met and phenformin induced activation/phosphorylation of aPKC in L6 myotubes. However, although cellular depletion of aPKC (>90%) led to loss in biguanide-induced aPKC phosphorylation, it had no effect on Met-stimulated GU, whereas inhibitors targeting novel/conventional PKCs caused a significant reduction in biguanide-induced GU. Our findings indicate that although Met activates AMPK, a significant component of Met-stimulated GU in muscle cells is mediated via an AMPK-independent mechanism that involves novel/conventional PKCs. © 2012 by The American Society for Biochemistry and Molecular Biology, Inc.

UR - http://www.scopus.com/inward/record.url?partnerID=yv4JPVwI&eid=2-s2.0-84862001123&md5=c9b5c75e0fd59cee8ef45a027060e859

U2 - 10.1074/jbc.M111.330746

DO - 10.1074/jbc.M111.330746

M1 - Article

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 24

VL - 287

SP - 20088

EP - 20099

ER -

Documents

Library & Learning Centre

Contact | Accessibility | Policy